No hype...if all goes well this technology will be sought after...and buyout will most likely happen...I think a buck a share would be fine just for pancreatic cancer...if a suitor wants to dabble in diabetes and mj...then 3 bucks or more is fine with me.
News 
Market Data 
Discover 
